Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase NA 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Dermatologic 1

Conditions

Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Papillary renal cell carcinoma, sporadic 1 Melanoma 1 Lung Neoplasms 1 Hereditary leiomyomatosis and renal cell cancer 1 Healthy Volunteers 1 Fallopian Tube Mucinous Adenocarcinoma 1 Ependymoma 1 Craniopharyngioma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 195 Cisplatin 117 Paclitaxel 107 Pemetrexed 106 Docetaxel 96 Gemcitabine 89 Radiotherapy 83 Erlotinib Hydrochloride 58 Bevacizumab 55 Etoposide 49 durvalumab 39 pembrolizumab 38 Nivolumab 31 Specimen Handling 30 Magnetic Resonance Spectroscopy 30 Irinotecan 27 Radiosurgery 26 osimertinib 24 Gefitinib 24 Drug Therapy 23 Vinorelbine 22 atezolizumab 20 Topotecan 20 Radiation 16 Cetuximab 16 Taxes 15 Surgical Procedures, Operative 14 Neoadjuvant Therapy 13 Filgrastim 13 Chemotherapy, Adjuvant 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lung Neoplasms × Contrast Media × Clear all

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡